Danaher Corp (DHR) Common Stock USD0.01

Sell:$223.07Buy:$223.12$1.05 (0.47%)

Prices delayed by at least 15 minutes
Sell:$223.07
Buy:$223.12
Change:$1.05 (0.47%)
Prices delayed by at least 15 minutes
Sell:$223.07
Buy:$223.12
Change:$1.05 (0.47%)
Prices delayed by at least 15 minutes

Company Information

About this company

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a range of instruments, consumables, services and software that are primarily used by customers to study genomics and the basic building blocks of life, including deoxyribonucleic acid (DNA)and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.

Key people

Steven M. Rales
Chairman of the Board
Rainer M. Blair
President, Chief Executive Officer, Director
Matthew R. McGrew
Chief Financial Officer, Executive Vice President
Christopher P. Riley
Executive Vice President
Julie Sawyer Montgomery
Executive Vice President - Diagnostics
Jose-Carlos Gutierrez-Ramos
Senior Vice President, Chief Science Officer
Brian W. Ellis
Senior Vice President, General Counsel
Georgeann F. Couchara
Senior Vice President - Human Resources
William H. King
Senior Vice President - Strategic Development
Daniel A. Raskas
Senior Vice President - Corporate Development
Linda P. Hefner Filler
Lead Independent Director
Mitchell P. Rales
Director
Feroz Dewan
Independent Director
Teri L. Liststoll
Independent Director
Jessica L. Mega
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Technology
  • Industry
    Scientific & Technical Instr.
  • ISIN
    US2358511028
  • Market cap
    $179.01bn
  • Employees
    61,000
  • Shares in issue
    883.98m
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.